Cargando…
Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation
Amyloid precursor protein (APP), upon proteolytic degradation, forms aggregates of amyloid β (Aβ) and plaques in the brain, which are pathological hallmarks of Alzheimer’s disease (AD). Cathepsin B is a cysteine protease enzyme that catalyzes the proteolytic degradation of APP in the brain. Thus, ca...
Autores principales: | Chitranshi, Nitin, Kumar, Ashutosh, Sheriff, Samran, Gupta, Veer, Godinez, Angela, Saks, Danit, Sarkar, Soumalya, Shen, Ting, Mirzaei, Mehdi, Basavarajappa, Devaraj, Abyadeh, Morteza, Singh, Sachin K., Dua, Kamal, Zhang, Kam Y. J., Graham, Stuart L., Gupta, Vivek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391575/ https://www.ncbi.nlm.nih.gov/pubmed/34440715 http://dx.doi.org/10.3390/cells10081946 |
Ejemplares similares
-
Retinal thickness and vascular parameters using optical coherence tomography in Alzheimer’s disease: a meta-analysis
por: Sheriff, Samran, et al.
Publicado: (2023) -
Correction to: Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement
por: Sharma, Samridhi, et al.
Publicado: (2022) -
Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement
por: Sharma, Samridhi, et al.
Publicado: (2022) -
A Proteomic View of Cellular and Molecular Effects of Cannabis
por: Abyadeh, Morteza, et al.
Publicado: (2021) -
Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s Disease
por: Abyadeh, Morteza, et al.
Publicado: (2021)